The Valley Desk

NCT04136184 · Interventional trial

NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Overall registry status Completed

Phase 3

Conditions Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov